Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders
US9603869B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2016 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | May 21, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns methods and compositions for treating a neuropsychiatric disorder, wherein the method comprises administering an effective amount of a co-crystal of lithium to a subject in need thereof, wherein the co-crystal comprises lithium, or a pharmaceutically acceptable salt thereof, and an amino acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.